{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:46:44Z","timestamp":1791661604221,"version":"4.3.4"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32 DA007288"],"award-info":[{"award-number":["T32 DA007288"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R25 DA020537"],"award-info":[{"award-number":["R25 DA020537"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K02 DA039229"],"award-info":[{"award-number":["K02 DA039229"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2018.00277","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T04:26:17Z","timestamp":1532406377000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":131,"title":["Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review"],"prefix":"10.3389","volume":"9","author":[{"given":"Jennifer L.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo F.","family":"Mateus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen T.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudie E.","family":"Back","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"B2","volume-title":"Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health","author":"Hedden","year":"2015"},{"key":"B3","article-title":"United Nations Office on Drugs and Crime: World Drug Report 2017","author":"Merz","year":"2017","journal-title":"SIRIUS-Zeitschrift f\u00fcr Strategische Analysen"},{"key":"B4","volume-title":"Drug Overdose Deaths in the United States, 1999\u20132015. NCHS Data Brief.","author":"Hedegaard","year":"2017"},{"key":"B5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/08897077.2014.941085","article-title":"Exploring the concepts of abstinence and recovery through the experiences of long-term opiate substitution clients","volume":"36","author":"Notley","year":"2015","journal-title":"Subst Abus."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087366","article-title":"Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis","author":"Skinner","year":"2014","journal-title":"PLoS ONE"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.euroneuro.2016.10.008","article-title":"Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy","volume":"26","author":"Mann","year":"2016","journal-title":"Eur Neuropsychopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bcp.2007.06.039","article-title":"Glutamatergic substrates of drug addiction and alcoholism","volume":"75","author":"Gass","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bpsc.2017.04.006","article-title":"Prefrontal connectivity and glutamate transmission: relevance to depression pathophysiology and ketamine treatment","volume":"2","author":"Abdallah","year":"2017","journal-title":"Biol Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrd.2017.16","article-title":"Targeting glutamate signalling in depression: progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyu039","article-title":"Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder","author":"Niciu","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S117146","article-title":"Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies","author":"Han","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat"},{"key":"B15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neubiorev.2017.03.010","article-title":"Ketamine as a rapid-acting agent for suicidal ideation: a meta-analysis","volume":"77","author":"Bartoli","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/jcpt.12497","article-title":"What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities","volume":"42","author":"Strasburger","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1098\/rstb.2011.0357","article-title":"A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists","volume":"367","author":"Duman","year":"2012","journal-title":"Phil Trans R Soc B"},{"key":"B18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jad.2013.11.014","article-title":"A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action","volume":"156","author":"Naughton","year":"2014","journal-title":"J Affect Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biopsych.2013.08.009","article-title":"The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers","volume":"76","author":"Dakwar","year":"2014","journal-title":"Biol Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/mp.2016.39","article-title":"Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial","volume":"22","author":"Dakwar","year":"2017","journal-title":"Mol Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0740-5472(02)00275-1","article-title":"Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up","volume":"23","author":"Krupitsky","year":"2002","journal-title":"J Subst Abus Treat"},{"key":"B22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/02791072.2007.10399860","article-title":"Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence","volume":"39","author":"Krupitsky","year":"2007","journal-title":"J Psychoact Drugs"},{"key":"B23","first-page":"625","article-title":"Effects of ketamine on precipitated opiate withdrawal","volume":"42","author":"Jovai\u0161a","year":"2006","journal-title":"Medicina"},{"key":"B24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/02791072.1997.10400185","article-title":"Ketamine psychedelic therapy (KPT): a review of the results of ten years of research","volume":"29","author":"Krupitsky","year":"1997","journal-title":"J Psychoact Drugs"},{"key":"B25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1060028014555859","article-title":"Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome","volume":"49","author":"Wong","year":"2015","journal-title":"Ann Pharmacother"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.01.005","article-title":"A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: results from a randomized, controlled laboratory study","author":"Dakwar","year":"2018","journal-title":"Neuropharmacology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12888-016-1112-2","article-title":"Experience of the use of ketamine to manage opioid withdrawal in an addicted woman: a case report","volume":"16","author":"Lalanne","year":"2016","journal-title":"BMC Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1876386301104010001","article-title":"Use of ketamine in ameliorating opioid withdrawal symptoms during an induction phase of buprenorphine","volume":"4","author":"Omoigui","year":"2011","journal-title":"Open Pain J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1213\/XAA.0000000000000653","article-title":"Use of Ketamine in a multimodal analgesia setting for rapid opioid tapering in a profoundly opioid-tolerant patient: a case report","volume":"10","author":"Strickler","year":"2018","journal-title":"AA Pract"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1318","DOI":"10.4088\/JCP.17lr11789","article-title":"Antidepressant response and dissociative effects after ketamine treatment: two sides of the same coin?","volume":"78","author":"Bartoli","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"B31","first-page":"287","article-title":"Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression","volume":"34","author":"Sos","year":"2013","journal-title":"Neuroendocrinol Lett"},{"key":"B32","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3109\/15622975.2016.1139747","article-title":"Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review","volume":"18","author":"Cooper","year":"2017","journal-title":"World J Biol Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2018.00277\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T04:26:22Z","timestamp":1532406382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2018.00277\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":32,"alternative-id":["10.3389\/fpsyt.2018.00277"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2018.00277","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]},"article-number":"277"}}